济川药业：子公司获药品注册证书

Core Viewpoint - Jichuan Pharmaceutical (600566) has received approval from the National Medical Products Administration for its compound polyethylene glycol (3350) electrolyte powder, which is intended for the treatment of chronic constipation and fecal impaction [1] Company Summary - Jichuan Pharmaceutical's wholly-owned subsidiary, Jichuan Limited, has been granted a drug registration certificate for its product, which is chocolate-flavored to enhance palatability [1] - The total research and development expenditure for this drug has reached approximately 11.1886 million yuan (unaudited), all of which has been expensed [1] - The approval of the drug registration certificate is expected to have a positive impact on the company's future development [1]